Ysebaert L - Search Results

1

Immune thrombocytopenic purpura following human papillomavirus vaccination.

Pugnet G, Ysebaert L, Bagheri H, Montastruc JL, Laurent G. Pugnet G, et al. Among authors: ysebaert l. Vaccine. 2009 Jun 8;27(28):3690. doi: 10.1016/j.vaccine.2009.04.004. Epub 2009 Apr 23. Vaccine. 2009. PMID: 19464550 No abstract available.

2

Effectiveness of telephone support during chemotherapy in patients with diffuse large B cell lymphoma: the Ambulatory Medical Assistance (AMA) experience.

Compaci G, Ysebaert L, Obéric L, Derumeaux H, Laurent G. Compaci G, et al. Among authors: ysebaert l. Int J Nurs Stud. 2011 Aug;48(8):926-32. doi: 10.1016/j.ijnurstu.2011.01.008. Epub 2011 Feb 23. Int J Nurs Stud. 2011. PMID: 21349519

3

Cancer stem cells of differentiated B-cell malignancies: models and consequences.

Gross E, Quillet-Mary A, Ysebaert L, Laurent G, Fournie JJ. Gross E, et al. Among authors: ysebaert l. Cancers (Basel). 2011 Mar 25;3(2):1566-79. doi: 10.3390/cancers3021566. Cancers (Basel). 2011. PMID: 24212774 Free PMC article.

4

First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis.

Michallet AS, Cazin B, Bouvet E, Oberic L, Schlaifer D, Mosser L, Salles G, Coiffier B, Laurent G, Ysebaert L. Michallet AS, et al. Among authors: ysebaert l. J Geriatr Oncol. 2013 Apr;4(2):141-7. doi: 10.1016/j.jgo.2013.01.002. Epub 2013 Feb 26. J Geriatr Oncol. 2013. PMID: 24071539

5

Protein phosphatase-2A activation is a critical step for enzastaurin activity in chronic lymphoid leukemia cells.

Liffraud C, Quillet-Mary A, Fournié JJ, Laurent G, Ysebaert L. Liffraud C, et al. Among authors: ysebaert l. Leuk Lymphoma. 2012 May;53(5):966-72. doi: 10.3109/10428194.2011.634041. Epub 2011 Dec 6. Leuk Lymphoma. 2012. PMID: 22023517

6

Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.

Laurent C, Do C, Gascoyne RD, Lamant L, Ysebaert L, Laurent G, Delsol G, Brousset P. Laurent C, et al. Among authors: ysebaert l. J Clin Oncol. 2009 Sep 1;27(25):4211-6. doi: 10.1200/JCO.2008.21.5020. Epub 2009 Jul 27. J Clin Oncol. 2009. PMID: 19636007

7

Characterization of bone marrow lymphoid infiltrates after immunochemotherapy for follicular lymphoma.

Laurent C, de Paiva GR, Ysebaert L, Laurent G, March M, Delsol G, Brousset P. Laurent C, et al. Among authors: ysebaert l. Am J Clin Pathol. 2007 Dec;128(6):974-80. doi: 10.1309/LREBX069UXDYMBXV. Am J Clin Pathol. 2007. PMID: 18024323

8

Clinical activity of a new regimen combining gemcitabine and alemtuzumab in high-risk relapsed/refractory chronic lymphocytic leukemia patients.

Oberic L, Vaillant W, Hebraud B, Recher C, Suc E, Houyau P, Laurent G, Ysebaert L. Oberic L, et al. Among authors: ysebaert l. Eur J Haematol. 2015 Jan;94(1):37-42. doi: 10.1111/ejh.12391. Epub 2014 Sep 17. Eur J Haematol. 2015. PMID: 24939411

9

Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey.

Compaci G, Conte C, Oberic L, Ysebaert L, Laurent G, Despas F. Compaci G, et al. Among authors: ysebaert l. BMC Cancer. 2019 Dec 3;19(1):1178. doi: 10.1186/s12885-019-6337-2. BMC Cancer. 2019. PMID: 31795958 Free PMC article.

10

Recombinant human IL-15 trans-presentation by B leukemic cells from chronic lymphocytic leukemia induces autologous NK cell proliferation leading to improved anti-CD20 immunotherapy.

Laprevotte E, Voisin G, Ysebaert L, Klein C, Daugrois C, Laurent G, Fournie JJ, Quillet-Mary A. Laprevotte E, et al. Among authors: ysebaert l. J Immunol. 2013 Oct 1;191(7):3634-40. doi: 10.4049/jimmunol.1300187. Epub 2013 Aug 30. J Immunol. 2013. PMID: 23997218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters